2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$55.90-$0.14 (-0.25%)
Price as of Jul 13, 2026 7:55 PM EDT- $14.2BMarket Cap
- 22.95%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$55.90-$0.14 (-0.25%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $56.04 | ||
Change | -$0.46 (-0.81%) | ||
Open | $56.24 | ||
High | $56.47 | ||
Low | $55.08 | ||
Previous Close | $56.50 | ||
Volume | 2,844,304 | ||
30-Day Average Volume | 2,988,589 | ||
1-Week Change | 0.92% | ||
1-Month Change | 5.48% | ||
1-Year Change | 22.95% | ||
3-Year Change | 189.61% | ||
5-Year Change | 216.43% | ||
Fundamentals | |||
Shares Outstanding | 251.4M | ||
Total Assets | $2.6B | ||
Market Cap | $14.2B | ||
Enterprise Value | $14.0B | ||
Period: QTR TTM FY | |||
Revenue | $555.0M | ||
Net Income | $210.5M | ||
Free Cash Flow | $250.3M | ||
EBIT | $267.7M | ||
EBITDA | $274.6M | ||
Net Working Capital | $837.7M | ||
EPS | $0.79 | ||
Enterprise Value/EBITDA | 51 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 7 | ||
P/E | 72 | ||
PEG | -7 | ||
Price/Free Cash Flow | 57 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue